Introduction
A pressurized metered dose inhaler (pMDI) with spacer is preferred asthma treatment method for children of all ages due to its greater convenience, more effective lung deposition, lower risk of adverse effects, and lower cost as per Global Strategy for Asthma Management and Prevention (GINA) report. 1 Like other respiratory drug delivery systems, even when used correctly, the pMDI only delivers approximately 10 -20% of the nominal dose per actuation or puff. Deposition may be lower in children due to differences in breathing pattern or in cases where the technique is less than optimal. 2 Tidal breathing with a pMDI with spacer is as effective as the single breath method as per Scottish Intercollegiate Guidelines Network (SIGN) recommendations. 3 A study on the deposition of aerosol in children suggests better deposition of the medication with a single maximal inhalation with breath-hold as compared with tidal breathing. 4 Breath-holding is usually recommended after the aerosol inhalation, but there is limited information on the clinical importance of breath-holding in the case of children. It has been observed that, in adults, breath-holding only improves lung deposition after an extremely slow inhalation, which may be difficult for children to perform. 5 Information on comparative efficacy of either method is limited.
Thus, the objective of the present study is to compare the relative improvement in peak expiratory flow (PEF) with a single maximal inhalation with breath-hold versus 5 tidal breaths during inhalation of salbutamol from a pMDI with valved holding chamber (VHC) in children 5-15 y of age with asthma.
Methods
The study was conducted between August and December 2012 at the out-patient pediatric chest clinic of a tertiary care hospital in New Delhi, India. Ethical clearance was obtained from the institutional ethics committee. Informed consent from parents and assent from children above 7 y were also taken.
We enrolled children 5-15 y of age diagnosed with asthma by a physician and receiving inhalation therapy with a pMDI and VHC, who could perform the maneuver for measuring PEF and who could hold their breath for 5 s or more. Children with exacerbations of asthma (ie, as per Global Initiative for Asthma [GINA] report: breathlessness on walking or talking or at rest; breathing frequency Ͼ 30/min; moderate or loud wheeze; accessory or suprasternal retractions; unable to talk in sentences; S aO 2 on room air Ͻ 95%); congenital abnormalities of the chest, cardiovascular or neuromuscular disease; anthropometric parameters less than third percentile; regular long-acting ␤ 2 agonist (salmeterol, formoterol) use; and those who had received ␤ 2 agonist (salbutamol), methylxanthines (theophylline), or anti-cholinergic drugs (ipratropium bromide) 6 h before the observation were excluded from the study.
The intervention, that is, single maximal inhalation with a breath-hold technique, was demonstrated by the investigator to the children in the experimental group, and they were asked to demonstrate in return to ensure that they followed the procedure. Children were administered 2 puffs of salbutamol using a pMDI (with an interval of 60 s between each puff, each puff being 100 g) with a VHC (Zerostat VT spacer, Cipla, Mumbai, India; a small volume static free spacer with a valve) and asked to inhale through the inbuilt mouthpiece either by the 5 tidal breaths (control group) or single maximal inhalation with a breathhold (experimental group) of at least 5 s duration (maximum 10 s) with each puff. The subject was then asked to exhale into the VHC without removing the mouthpiece. The mouthpiece of the VHC has small slitlike openings, which allow exhaled air to move out as the one-way valve closes the spacer chamber. For the tidal breathing method, the multiple breathing technique steps as per GINA 6 and Indian Academy of Pediatrics Respiratory Chapter recommendations 7 were followed. The children were able to take the medicine through the VHC without a mask. The duration of breath-hold was measured in seconds using a stopwatch. PEF after salbutamol inhaler use was assessed 30 min after the initial dose. In the event that a child, after being randomized into the experimental group, was unable to perform the breath-hold for at least 5 s during actual assessment with salbutamol, then the subject was considered as attrition.
PEF was assessed using a peak expiratory flow meter (Breathe-O-meter, Cipla, Mumbai, India) with the subject in standing position. The inter-class consistency in obtaining PEF between the investigator and the asthma clinic staff was assessed among 10 children suffering from asthma and was found to be 99.6%. Three consecutive readings for each child were taken, from which the best value was recorded. If a reading was hindered due to cough or sneeze, it was not considered.
The sample size was calculated based on the pilot study performed on 10 subjects. At the end of the pilot study, assuming that the baseline PEF values are the same in both groups, the improvement in PEF from baseline was found to be 32.6 Ϯ 9 L/min in the experimental group and 27.6 Ϯ 9 L/min in the control group. Computing the above
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Current knowledge
A pressurized metered dose inhaler (pMDI) with spacer is the preferred device for aerosol therapy for treatment of asthma in children. pMDIs have greater convenience, more effective lung deposition, lower risk of adverse effects, and lower cost. When used correctly, pMDIs only deliver approximately 10 -20% of the nominal dose per actuation. Deposition may be lower in children due to differences in breathing pattern or in cases where the technique is less than optimal.
What this paper contributes to our knowledge
A single maximal inhalation with a breath-hold technique was not superior to the 5 tidal breathing technique in improving the peak expiratory flow in children with asthma who use a pMDI with a valved holding chamber. Children can be taught either of the methods in accordance with their ability to perform a particular technique or their preference for administration of inhaled medications for asthma.
values with an alpha of 5% and power of 80% and 1:1 ratio, by the method of change, we needed to enroll 37 in each group, ie, 74 cases. Considering an expected attrition rate of 10%, it was decided to enroll 82 cases (41 in each arm).
The children's ability to perform a single maximal inhalation with breath-hold technique can vary with age. To address this issue, we stratified eligible children into age groups such as 5-7 y, 8 -10 y, and 11-15 y. Children in each strata were randomized into the single maximal inhalation with a breath-hold group or the 5 tidal breaths group using numbered opaque envelops for allocation concealment. Stratified randomization was achieved using a computerized random number generator (http://www. randomization.com/).
The data are represented as mean Ϯ SD. The categorical data are represented as n (%) and were analyzed by applying chi-square test or Fisher's exact test, wherever necessary. The continuous data (ie, the mean improvement in PEF between the experimental and control groups) were analyzed using Student t test or Mann-Whitney test wherever necessary. To find the improvement within each treatment modality for pre-and post-PEF values, paired t test was applied. A P value of Ͻ .05 was considered as statistically significant. Analysis of variance was used to compare breath-hold duration among the 3 age groups. SPSS 20.0 (SPSS, Chicago, Illinois) was used for statistical analysis.
Results
During the study period, 83 children were randomized into the experimental and control groups. One subject in the experimental group was considered as attrition, as he was unable to hold his breath for a minimum of 5 s during the actual performance and was therefore excluded. Thus, data from 82 subjects were available for final analysis, ie, 41 subjects in each arm (65 [79.3%] boys and 17 [20.7%] girls with a mean age of 8.8 Ϯ 2.5 y) were included (Fig.  1) . The baseline characteristics of the study subjects are shown in Table 1 . Table 2 shows the comparison of improvement in PEF within as well as between the groups. There was significant improvement in the PEF, from baseline (pre-intervention) to post-intervention within the single maximal inhalation with breath-hold group and tidal breathing group independently at a P value Ͻ .001. The mean difference in improvement in the PEF between the single maximal inhalation with a breath-hold and 5 tidal breath groups was 30.0 Ϯ 18.16 and 28.29 Ϯ 13.94 L/min, respectively, and was not found to be statistically significant (P ϭ .88). The mean percentage improvement in PEF from baseline was 17.52 Ϯ 10.05 L/min in the experimental group and 17.45 Ϯ 9.19 L/min in the control group and was found to be comparable (P ϭ .82). A total of 16 (39.0%) subjects in the single maximal group and 11 (26.8%) subjects in the The mean breath-hold duration was assessed for 41 subjects across all age groups and was found to be 9.2 Ϯ 1.4 s during the first actuation (puff) of pMDI; during the second actuation, it was 8.9 Ϯ 1.5 s. Comparisons of breathhold duration in different age groups (5-7 y, 8 -10 y, 11-15 y) during both first and second actuation were comparable (P ϭ .46 and .54 in the first and second actuation, respectively). With the exception of one child in the 5-7 y category, all other children enrolled were able to perform the breath-hold maneuver in our study.
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Discussion
In this study, we did not observe any significant difference in the improvement in PEF after inhalation of salbutamol using a pMDI and VHC by either single maximal inhalation with a breath-hold technique or 5 tidal breaths technique.
It has been observed that many children who suffer from asthma use their inhaler devices incorrectly, even after instruction for correct use. 8, 9 The most difficult skill for children using a metered-dose inhaler was progressive inhalation of the medicine slowly and deeply through the mouth and the need to hold their breath for a count of 10. 10 -12 A simple and efficient method to deliver drug through a pMDI in children must be identified to improve compliance and symptom control, and to minimize side effects. Patients can take a slow single breath to retrieve the medication or take tidal breaths from the chamber as per the Global Initiative on Asthma. There are very few studies done in this area in children to compare effectiveness of either method. The usual practice is to use the 5 tidal breath method. Therefore, we decided to compare the effectiveness of deep inhalation over tidal breathing during pMDI use.
We used PEF as the main outcome variable to assess the 2 inhalation techniques. Spirometry parameters including FEV 1 may be more relevant as they are more sensitive markers to assess the response to bronchodilator. An alternative method to compare the 2 inhalation techniques may be the documentation of deposition of aerosol in lungs by radionuclear tracer.
We concluded that the single maximal inhalation with a breath-hold technique is not superior to the 5 tidal breath technique in improving the PEF in children with asthma using pMDI and VHC. The findings of our study are similar to the findings of James et al. 13 They performed a cross-over design to demonstrate that there was no significant difference in FEV 1 and FEF 25-75% with salbutamol pMDI delivered via a spacing device (Volumatic, 750 mL) between the panting technique and single breath followed by a breath-hold maneuver in 21 subjects with a mean age of 10.9 Ϯ 3.3 y. There are limited data on clinical studies with a similar outcome on this topic.
There are several studies on drug deposition. Roller et al 4 found that inhalation of the extra-fine formulation of 99m Tc-labeled hydrofluoroalkane-beclomethasone dipropionate with the breath-hold technique (n ϭ 12) significantly improved lung deposition compared with tidal breathing (n ϭ 12) across children 4 -15 y of age. The adjusted mean of lung deposition in the breath-hold group was 1.6 times higher than that in the tidal group in children 5-7 y of age (n ϭ 4 in each arm), although the difference was not statistically significant due to the small sample size. This is in contradiction to the findings of our study. However, this may be due to the difference in the outcome variable and the drug used.
Schultz et al 14 tried to determine the number of breaths required to inhale salbutamol from different spacers/VHCs by recording breathing patterns of children 2-7 y of age. The children were asked to inhale placebo from 4 different spacers/VHCs, and their breathing patterns were simulated by a flow generator. The amount of drug deposition on inspiratory filters was used as the outcome to measure improvement in drug delivery. They demonstrated that single maximal inhalation (without breath-hold) did not result in improved drug delivery, compared with tidal breathing, for young children 2-7 y of age while inhaling salbutamol from different spacer/VHCs. This finding is similar to the findings of our study, although they are not comparable because the outcome variable and type of population used were different.
Studies have shown that there are inconsistencies with the technique of inhalation in the case of children (especially with the single maximal inhalation with a breathhold maneuver). In a few studies, the authors assessed appropriateness of pMDI techniques including ability to breath-hold, and they found that fewer than 50% of subjects could hold their breath for a minimum of 5 s. Bhukart et al 12 reported that the most common mistake in the pretest was the inability to hold the breath for at least 10 s after actuation (56%). Even after training for pMDI use and assessing within a short time of 1-4 weeks after training, approximately one fifth of the children still exhibited incorrect pMDI use, especially failure to breath-hold. Chen et al 15 also had similar results, in which they found that only 35.5% children could hold their breath for 10 s. However, we found that children were able to breath-hold for Ͼ 5 s (mean duration of 9.2 Ϯ 1.4 s and 8.9 Ϯ 1.5 s during first and second actuations, respectively). Roller et al 4 and Deerojanawong et al 16 also found that children included in the study were able to maintain the breath-hold for Ն 5 s.
The findings of this study may not be generalizable, as it was a hospital-based study. A major limitation of this study was the use of the PEF instead of detailed spirom-etry to assess outcome; although spirometry parameters are more sensitive, measuring PEF was more feasible and less time-consuming. PEF has a significantly larger degree of variability than FEV 1 , the accepted standard for the measurement of airway caliber. FEV 1 may be as much as 35% lower or up to 15% higher than the PEF for patients with obstructive lung diseases. There is also a fairly wide normal range, and PEF measurements do not necessarily parallel those of FEV 1 . Children's ability to perform the breath-hold maneuver could have been influenced by the Hawthorne effect. We included only children older than 5 y, to ensure proper technique and measurement of PEF in the clinic. The investigator was not blinded to the intervention.
Conclusions
The single maximal inhalation with a breath-hold technique is not superior to the 5 tidal breath technique in improving the PEF in children with asthma who use pMDI with valved holding chamber. Children can, therefore, be taught either of the methods in accordance with their ability to perform a particular technique or their preference for administration of inhaled medications for asthma.
